Description
Introduction Of Bryxta 400mg Injection:
Bryxta 400mg Injection is a monoclonal antibody used to treat metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum. Cancer is a condition where cells in a specific part of the body grow and reproduce uncontrollably. Cancer can start in one region of the body and spread to other parts. This is referred to as metastasis.
Bryxta 400mg Injection contains ‘Bevacizumab’ that works against vascular endothelial growth factor (VEGF) which is found on the lining of lymph and blood vessels. VEGF causes blood vessels to grow within tumours which provide oxygen and nutrients to the tumour. Inhibition of vascular endothelial growth factor limits the flow of oxygen and nutrients to the tumour, causing it to shrink or cease developing. Thus, it helps treat cancers.
Bryxta 400mg Injection will be administered by a healthcare professional; do not self-administer. Based on your medical condition, your doctor will decide the dose and duration. In some cases, Bryxta Injection may cause loss of appetite, constipation, fever, nosebleeds, change in speech, and taste. The majority of these side effects do not require medical treatment and fade away with time. However, consult your doctor if the side effects persist or worsen
Avoid taking Bryxta 400mg Injection if you are pregnant. Use effective contraception during the treatment and for 6months after the last dose. Injection may cause sleepiness and fainting, so avoid driving while on treatment with Bryxta 400 Injection. Do not breastfeed during the treatment and for 6months after the last dose of Bryxta Injection. Keep your doctor informed about your health condition and all the medicines you take to rule out any side effects.
Active Ingredient/Salt:
- Bevacizumab
Uses Of Bryxta 400mg Injection:
Bryxta 400mg Injection is used in the treatment of Metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, and cancer of the colon and rectum. The detailed uses of Bryxta 400 Injection are as follows:
- Colorectal Cancer: Bryxta 400 Injection is used in combination with chemotherapy for metastatic cases.
- Non-Small Cell Lung Cancer (NSCLC): Bryxta 400 Injection helps slow tumor growth and spread when combined with carboplatin and paclitaxel.
- Ovarian, Cervical, and Peritoneal Cancer: Bryxta 400 Injection is often used post-surgery or with chemotherapy to improve outcomes.
- Renal Cell Carcinoma (Kidney Cancer): Bryxta 400 Injection enhances treatment efficacy when paired with other agents.
- Glioblastoma (Brain Tumor): Bryxta 400 Injection is approved for recurrent cases to reduce tumor vascularization.
- Hepatocellular Carcinoma (Liver Cancer): Bryxta 400 Injection is used in combination with other drugs for advanced stages.
Benefits Of Bryxta 400mg Injection:
In Cancer of colon and rectum
Cancer of the colon and rectum, also known as colorectal cancer (CRC) or bowel cancer, is the development of cancer from two corridor of the large intestine, videlicet, the colon or rectum. In this type of cancer, the person may notice symptoms similar as blood in the coprolite, a change in bowel movements, weight loss, and fatigue. Bryxta 400mg Injection treats and also lowers the threat of developing farther cancerous growths (cysts) and bowel cancer. It kills or stops the growth of cancer cells and also prevents the addition of cancer cells.
Side effects of Bryxta 400mg Injection:
- Nosebleed
- Headache
- Stuffy Nose
- Excess Protein In Urine
- Altered Or Impaired Sense Of Taste
- Dry Skin
- Excessive Tears/ Watery Eyes
How Bryxta 400mg Injection Works:
Bryxta 400mg Injection contains ‘Bevacizumab’ that works against vascular endothelial growth factor (VEGF) which is found on the lining of lymph and blood vessels. VEGF causes blood vessels to grow within tumours which provide oxygen and nutrients to the tumour. Inhibition of vascular endothelial growth factor limits the flow of oxygen and nutrients to the tumour, causing it to shrink or cease developing. Thus, it helps treat cancers.
Medium Of Action Bryxta 400mg Injection:
Bryxta 400mg Injection is aanti-angiogenic drug. It works by blocking a protein called vascular endothelial growth factor (VEGF). This stops the conformation of blood vessels that bring oxygen and nutrients to cancerous cells.
Reviews
There are no reviews yet.